Sodium oxybate: Review of use in alcohol dependence
2025.06.23
Active substance: odium oxybate
23.06.2025 - Procedure started
EMA starts review of sodium oxybate in alcohol dependence
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
EMA’s human medicines committee (CHMP) has started a review of medicines containing sodium oxybate used in people with alcohol dependency to treat alcohol withdrawal syndrome and to support long term abstinence.